ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,775Medicare Part D Prescriptions Filled, Including Refills

Rank: 418 out of 1844

$445K Total Retail Price of All Prescriptions

Rank: 448 out of 1844

434 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 434 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

8% of this provider’s 434 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

0% of this provider’s 7,050 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LISINOPRIL 276 272 1 4
SIMVASTATIN 274 266 2 3
LEVOTHYROXINE SODIUM 254 223 3 1
AMLODIPINE BESYLATE 200 194 4 6
SERTRALINE HCL 192 149 5 21
GABAPENTIN 182 157 6 15
FUROSEMIDE 180 166 7 7
OMEPRAZOLE 171 153 8 5
METFORMIN HCL 162 151 9 8
ATORVASTATIN CALCIUM 148 138 10 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 136 125 11 20
CITALOPRAM HBR 124 105 12 19
NAMENDA 122 122 13 33
CARVEDILOL 117 101 14 22
PRAVASTATIN SODIUM 113 101 15 10
ALENDRONATE SODIUM 111 110 16 25
WARFARIN SODIUM 110 92 17 13
ATENOLOL 108 108 18 17
HYDROCODONE-ACETAMINOPHEN 93 74 S3 19 2
DONEPEZIL HCL 92 92 20 26
METOPROLOL TARTRATE 92 89 20 11
RANITIDINE HCL 86 73 22 38
LANTUS 86 84 22 42
TAMSULOSIN HCL 77 68 24 27
LOSARTAN POTASSIUM 74 60 25 24
POTASSIUM CHLORIDE 69 68 26 16
PROAIR HFA 69 41 26 45
RISPERIDONE 69 52 26 65
DIVALPROEX SODIUM 67 67 29 74
TRAMADOL HCL 66 65 30 18
POLYETHYLENE GLYCOL 3350 60 60 31 39
AZITHROMYCIN 60 50 31 37
HYDROCHLOROTHIAZIDE 59 56 33 9
CEPHALEXIN 59 57 33 56
TRAMADOL HCL-ACETAMINOPHEN 58 55 35 159
ALBUTEROL SULFATE 58 58 35 115
METFORMIN HCL ER 55 51 37 46
CYMBALTA 52 52 38 36
FINASTERIDE 52 52 38 137
TRIAMTERENE-HCTZ 51 50 40 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.